EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SOXC Enhances NGN2 ‐Mediated Reprogramming of Glioblastoma Cells Into Neuron‐Like Cells by Modulating RhoA and RAC1 / CDC42 Pathway Activity

Jianjing Yang iD, Xiaohong Zhu, Fan Wang, Zhen Chen, Ying Zhang, Jiawei Chen, Haoqi Ni, Chun-Li Zhang, Qichuan Zhuge

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Jianjing Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Glioblastoma, rac1 GTP-Binding Protein, rhoA GTP-Binding Protein, Nerve Tissue Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma represents the most frequently diagnosed malignant neoplasm within the central nervous system. Human glioblastoma cells can be phenotypically reprogrammed into neuron‐like cells through the forced expression of NEUROG2 and SOXC factors. NEUROG2 serves as a pioneer factor, establishing an initial framework for this transformation. However, the specific role of SOXC factors has not been fully elucidated.

Methods

In this study, we used ChIP‐seq to determine the potential target gene of NGN2. RNA‐seq has been used to evaluate the transcriptional change during NGN2‐SOX11‐mediated neuron reprogramming. Immunofluorescence was used to determine the neuron reprogramming efficacy and cell proliferation ability. ChIP‐qPCR, Co‐IP, and Western Blot were performed to investigate the mechanism.

Results

Our findings reveal that SOXC factors, in contrast to their previously identified function as transcriptional activators, act as transcriptional repressors. They achieve this by recruiting TRIM28 to suppress the expression of ECT2, a RhoGEF. This suppression results in the differential regulation of RhoA, RAC1, and CDC42 activities throughout the reprogramming process. We further establish that small molecules targeting RhoA and its effectors can substitute for SOXC factors in facilitating the neuronal reprogramming of glioblastoma cells.

Conclusion

These results underscore the pivotal role of SOXC factors' transcriptional repression and illuminate one of their specific downstream targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glioblastomarac1 GTP-Binding ProteinrhoA GTP-Binding ProteinNerve Tissue Proteinscdc42 GTP-Binding ProteinBasic Helix-Loop-Helix ProteinsNeuronsCellular ReprogrammingSOXC Transcription FactorsSignal TransductionHumansCell Line, TumorBrain Neoplasms

Stichwörter der Autor:innen

ECT2NGN2RAC1/CDC42RhoASOX4/11glioblastoma

Substanzen

rac1 GTP-Binding ProteinrhoA GTP-Binding ProteinNerve Tissue Proteinscdc42 GTP-Binding ProteinBasic Helix-Loop-Helix ProteinsSOXC Transcription FactorsRAC1 protein, humanRHOA protein, humanNEUROG2 protein, humanCDC42 protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Zhejiang-US Joint Laboratory for Aging and Neurological Disease Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Jianjing Yang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, J., Zhu, X., Wang, F., Chen, Z., Zhang, Y., Chen, J., Ni, H., Zhang, C. L., & Zhuge, Q. (2024). SOXC Enhances NGN2 ‐Mediated Reprogramming of Glioblastoma Cells Into Neuron‐Like Cells by Modulating RhoA and RAC1 / CDC42 Pathway Activity. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70075

Vancouver

Yang J, Zhu X, Wang F, Chen Z, Zhang Y, Chen J, et al. SOXC Enhances NGN2 ‐Mediated Reprogramming of Glioblastoma Cells Into Neuron‐Like Cells by Modulating RhoA and RAC1 / CDC42 Pathway Activity. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70075

BibTeX
@article{Yang2024,
  author = {Yang, Jianjing and Zhu, Xiaohong and Wang, Fan and Chen, Zhen and Zhang, Ying and Chen, Jiawei and Ni, Haoqi and Zhang, Chun-Li and Zhuge, Qichuan},
  title = {SOXC Enhances NGN2 ‐Mediated Reprogramming of Glioblastoma Cells Into Neuron‐Like Cells by Modulating RhoA and RAC1 / CDC42 Pathway Activity},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.70075}
}
Kostenlos starten →